EyePoint Pharmaceuticals, Inc.

Q4 2022 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filers
76
Total reported value, excl. options
$103M
Manager Report Date Value ($000) Shares